SA 2.2 Molecular Imaging in Breast Cancer

SA 2.2 Molecular Imaging in Breast Cancer

Bibliographic Details
Main Authors:	M. van Kruchten, E.G. de Vries
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623000759

Similar Items

Molecular imaging as biomarker for treatment response and outcome in breast cancer
by: Jasper J. L. van Geel, et al.
Published: (2023-05-01)

SA 3.2 Tumor microenvironment in early breast cancer
by: C. Denkert
Published: (2023-03-01)

Use of S2.2/DOX Magnetic Nanoliposomes in MR Molecule Imaging and Targeted Thermochemotherapy for Breast Cancer In Vitro
by: Yinxing Zhu MD, et al.
Published: (2023-08-01)

SA 8.3 Emerging new treatments in HER2 positive breast cancer
by: M. Piccart
Published: (2023-03-01)

SA 4.2 Local treatment in patients with high risk hereditary breast cancer
by: M.-J. Cardoso
Published: (2023-03-01)

Letter to the editor: Whither breast imaging in SA
by: Chris Markgraaf, et al.
Published: (1997-06-01)

SA 1.2 Access to evidence based radiation therapy for patients with early breast cancer
by: P. Poortmans, M.D., Ph.D.
Published: (2023-03-01)

Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients
by: Karen Zaguirre, et al.
Published: (2021-03-01)

2,2 `-Iminodiethanaminium 2,2 `-(disulfanyldiyl)dibenzoate dihydrate
by: Broker, G.A., et al.
Published: (2010)

SA 6.2 Benefits and risks of oncoplastic breast-conserving surgery
by: M.-J. Vrancken Peeters
Published: (2023-03-01)

SA scientists contribute to research on climatic change
by: E.G Brunke, et al.
Published: (2019-09-01)

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
by: Magdalena Mileva, et al.
Published: (2024-01-01)

Validation of PREDICT Version 2.2 in a Retrospective Cohort of Indian Women With Operable Breast Cancer
by: Nita S. Nair, et al.
Published: (2023-09-01)

Tetraarylantimony 2,2′-bipyridinecarboxylates: synthesis, photophysical and molecular docking studies
by: Ekaterina V. Artem’eva, et al.
Published: (2024-12-01)

Immunophenotyping invasive breast cancer: paving the road for molecular imaging
by: Vermeulen Jeroen F, et al.
Published: (2012-06-01)

SA 4.1 Imaging, screening & surveillance for individuals with increased hereditary breast cancer risk
by: S. Delaloge
Published: (2023-03-01)

SA 11.2 Premenopausal HR positive breast cancer: Who needs chemotherapy in the (neo)adjuvant setting?
by: P. Francis
Published: (2023-03-01)

Molecular Imaging of Breast Cancer: Present and future directions
by: David eAlcantara, et al.
Published: (2014-12-01)

SA 3.4 The future of breast cancer immunotherapy (PD, PDL, vaccines)
by: G. Curigliano
Published: (2023-03-01)

Editorial 2.2
by: Armando Rocha Júnior, et al.
Published: (2000-07-01)

2.2
Published: (2020-04-01)

Molecular subtypes and imaging phenotypes of breast cancer
by: Nariya Cho
Published: (2016-10-01)

Evaluation of Interleukin-22 and Toll-like receptor-2 as an Immunological Biomarkers in Breast Cancer Patients
by: Ikram Khazal Qasim Al-Hasso
Published: (2024-08-01)

MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor
by: Xiaochong Deng, et al.
Published: (2021-08-01)

Molecular imaging to support cancer immunotherapy
by: Elisabeth GE de Vries, et al.
Published: (2022-08-01)

SA 8.4 ER positive vs ER negative: tackling diversity in HER2 positive breast cancer
by: A. Prat
Published: (2023-03-01)

2,2′-Trisulfanediyldibenzoyl Chloride
by: R. Alan Aitken, et al.
Published: (2023-09-01)

Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer
by: Yuxin Mu, et al.
Published: (2023-12-01)

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer
by: M. C. Liefaard, et al.
Published: (2023-06-01)

4,12-Bis(2,2-dibromovinyl)[2.2]paracyclophane
Published: (2009-03-01)

Synthesis of New Planar-Chiral Linked [2.2]Paracyclophanes-<i>N</i>-([2.2]-Paracyclophanylcarbamoyl)-4-([2.2]Paracyclophanylcarboxamide, [2.2]Paracyclophanyl-Substituted Triazolthiones and -Substituted Oxadiazoles
by: Ashraf A. Aly, et al.
Published: (2020-07-01)

SA 11.4 Duration of endocrine therapy in early breast cancer
by: J. Huober
Published: (2023-03-01)

Cav2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization
by: Ying Xue, et al.
Published: (2022-09-01)

SaTransformer: Semantic‐aware transformer for breast cancer classification and segmentation
by: Jie Zhang, et al.
Published: (2023-11-01)

The Improvement of Flip (2,2) Visual Cryptography Images Using Two Key Images
by: Ratna Dewi, et al.
Published: (2016-09-01)

Editorial to Volume 22(2)
by: JH van Vuuren
Published: (2009-10-01)

Colophon 2.2
by: Tamas Komives
Published: (2016-06-01)

As endemias rurais na Folha SA.22 Belém, do projeto RADAM
by: Mario B. Aragão
Published: (1987-12-01)

Novel Molecular Classification of Breast Cancer with PET Imaging
by: Ngô Minh Toàn
Published: (2024-12-01)

Fluorescence molecular imaging probes for molecularclassification of breast cancer
by: Yue Xiuli, et al.
Published: (2021-06-01)